|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 47/12 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61K 38/17 | (2006.01) |
| (11) | Number of the document | 3911298 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20701703.9 |
| Date of filing the European patent application | 2020-01-16 | |
| (97) | Date of publication of the European application | 2021-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2023-11-15 |
| (46) | Date of publication of the claims translation | 2023-12-27 |
| (86) | Number | PCT/EP2020/051002 |
| Date | 2020-01-16 |
| (87) | Number | WO 2020/148372 |
| Date | 2020-07-23 |
| (30) | Number | Date | Country code |
| 201900658 | 2019-01-17 | GB | |
| 201905105 | 2019-04-10 | GB |
| (72) |
JOHNSON, Andy , GB
EBNER, Martin , GB
GRUDZIEN, Lukasz , GB
|
| (73) |
Immunocore Limited ,
92 Park Drive
Milton Park, Abingdon, Oxfordshire OX14 4RY,
GB
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Kompozicijos |
| FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2025-12-31 | 7 | 162.00 EUR |
| 2027-01-16 |